News & Updates

The extent of liver fibrosis appears to be higher among people living with HIV (PWH) who have metabolic dysfunction-associated steatotic liver disease (MASLD), despite lower NAFLD activity score (NAS) and less pronounced histological drivers of fibrosis, than among their counterparts who have no HIV, according to a study.

For young children with an upper respiratory tract infection, also known as common cold, treatment with hypertonic saline nasal drops is safe and beneficial, shortening recovery time by 2 days and, in turn, reducing household spread of the disease, according to the results of the ELVIS-Kids trial.

Nirmatrelvir-ritonavir has emerged as a key antiviral therapy in the fight against COVID-19, particularly for high-risk populations. Two recently published studies demonstrated the efficacy of nirmatrelvir-ritonavir in hospitalized patients with COVID-19 and in those with advanced kidney disease.

Individuals who have been vaccinated against COVID-19 appear to have a risk of new-onset seizure that is similar to that observed among unvaccinated individuals, according to the results of a meta-analysis.

A multidisciplinary nutritional support team (NST) can help improve the survival outcomes in patients with sepsis, according to a study. Such improvements are more pronounced in those aged ≥65 years who were admitted to the ICU.

The ENVIE* study demonstrates the real-world effectiveness of nirsevimab against hospitalization for bronchiolitis associated with respiratory syncytial virus (RSV) among infants <12 months of age in France.